Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food effect and mass balance of SHR0302 in healthy volunteers
NCT02892370Phase 1Unknown
- Sponsor
- Hengrui
- Start
- Aug 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ivarmacitinib in rheumatoid arthritis (RA) (2 arms), sponsored by Hengrui. Primary endpoints: Maximum Plasma Concentration, Area Under the Plasma Concentration-Time Curve and 1 more. Status: unknown.
02
Drugs
ivarmacitinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02892370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02892370.